Therapy Areas: Vaccines
Head of AstraZeneca France says COVID-19 vaccine situation encouraging
27 November 2020 -

The president of AstraZeneca France, Olivier Nataf, said on 27 November 2020 that the situation regarding the COVID-19 vaccine being developed by AstraZeneca is generally encouraging, even though a new trial will be needed, Reuters news agency reported on Friday.

Nataf was quoted as telling RTL radio: "We are in a context that is encouraging."

However, British pharmaceutical company AstraZeneca faces questions about its success rate, which some experts say could hinder its chances of gaining speedy US and EU regulatory approval, Reuters added.